Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PI103 | 0.1 | uM | Visfatin | 1 | ng/mL | 2 | M-CSF | 152.0 | 62 | |
N2586 | Sigma A6730 | 3.0 | uM | Visfatin | 1 | ng/mL | 2 | M-CSF | 158.0 | 44 | |
N2586 | JNK-IN-8 | 3.0 | uM | Visfatin | 1 | ng/mL | 2 | M-CSF | 130.0 | 70 | |
N2586 | JNK-IN-11 | 0.3 | uM | Visfatin | 1 | ng/mL | 2 | M-CSF | 142.0 | 44 | |
0 | M-CSF | 59.0 | 67 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 237.0 | 89 | ||||
RA2159 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 180.0 | 51 | |
RA2159 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 210.0 | 57 | |
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 143.0 | 53 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 116.0 | 56 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 156.0 | 76 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 249.0 | 76 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 252.5 | 36 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 217.0 | 45 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 223.0 | 62 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 148.0 | 63 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | M-CSF | 188.0 | 67 | |
0 | M-CSF | 57.0 | 58 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 168.0 | 50 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 204.0 | 73 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 125.0 | 60 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 206.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 199.0 | 72 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 157.0 | 61 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 282.0 | 53 |